会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Systems and methods for memory management on print devices
    • 打印设备上的内存管理系统和方法
    • US08099555B2
    • 2012-01-17
    • US12358816
    • 2009-01-23
    • Christopher Williamson
    • Christopher Williamson
    • G06F12/00G06F13/00G06F13/28
    • G06F12/0802G06F12/121G06K15/02G06K15/1828
    • Systems and methods disclosed permit flexible optimization of printer cache memories by specify criteria for determining cache membership for objects derived from a print data streams, wherein the objects may be associated with distinct reference counts. In some embodiments, the method may comprise the steps of: assigning an initial value to the reference count associated with an object, if the object is not present in the cache; incrementing the reference count by a first weight, if the object is already present in the cache; decrementing the reference count by a second weight, in response to an end-of-page event; and removing the object from the cache if the reference count is below a threshold.
    • 所公开的系统和方法允许通过指定用于确定从打印数据流导出的对象的高速缓存成员资格的标准来灵活地优化打印机高速缓存存储器,其中对象可以与不同的参考计数相关联。 在一些实施例中,该方法可以包括以下步骤:如果对象不存在于高速缓存中,则将初始值分配给与对象相关联的引用计数; 如果对象已经存在于缓存中,则将引用计数递增第一权重; 响应于页面结束事件,将引用计数减去第二权重; 并且如果引用计数低于阈值,则从缓存中移除该对象。
    • 3. 发明申请
    • Systems and Methods for Memory Management on Print Devices
    • 打印设备内存管理的系统和方法
    • US20100191912A1
    • 2010-07-29
    • US12358816
    • 2009-01-23
    • Christopher Williamson
    • Christopher Williamson
    • G06F12/08
    • G06F12/0802G06F12/121G06K15/02G06K15/1828
    • Systems and methods disclosed permit flexible optimization of printer cache memories by specify criteria for determining cache membership for objects derived from a print data streams, wherein the objects may be associated with distinct reference counts. In some embodiments, the method may comprise the steps of: assigning an initial value to the reference count associated with an object, if the object is not present in the cache; incrementing the reference count by a first weight, if the object is already present in the cache; decrementing the reference count by a second weight, in response to an end-of-page event; and removing the object from the cache if the reference count is below a threshold.
    • 所公开的系统和方法允许通过指定用于确定从打印数据流导出的对象的高速缓存成员资格的标准来灵活地优化打印机高速缓存存储器,其中对象可以与不同的参考计数相关联 在一些实施例中,该方法可以包括以下步骤:如果对象不存在于高速缓存中,则将初始值分配给与对象相关联的引用计数; 如果对象已经存在于缓存中,则将引用计数递增第一权重; 响应于页面结束事件,将引用计数减去第二权重; 并且如果引用计数低于阈值,则从缓存中移除该对象。
    • 7. 发明授权
    • Entity pages
    • 实体页面
    • US08484015B1
    • 2013-07-09
    • US12780651
    • 2010-05-14
    • Stephen WolframChristopher WilliamsonOyvind Tafjord
    • Stephen WolframChristopher WilliamsonOyvind Tafjord
    • G06F17/27G06F17/21G06F17/20G06F17/30
    • G06F17/30693G06F17/30654
    • An answer engine determines an entity related to a query from a user in a system designed for computation, search, or other activities involving the processing of queries. The system determines whether an entity page for the entity is stored in an answers database and, if so, retrieves and displays the stored entity page. If there is no stored entity page for the entity, the answer engine generates and displays an answer to the query and may optionally store the answer as an entity page. Additionally, the answer engine may pre-generate and store entity pages according to algorithmic variation of received queries and/or according to information received from external sources.
    • 答案引擎在用于计算,搜索或涉及处理查询的其他活动的系统中确定与来自用户的查询相关的实体。 系统确定实体的实体页面是否存储在答案数据库中,如果是,则检索并显示存储的实体页面。 如果实体没有存储的实体页面,则答案引擎生成并显示对查询的答案,并且可以可选地将答案存储为实体页面。 此外,应答引擎可以根据接收到的查询的算法变化和/或根据从外部源接收的信息来预生成和存储实体页面。
    • 9. 发明授权
    • Substituted pyrimidin-2-ones, the salts thereof, processes for their
preparation, pharmaceutical compositions containing them and a method
therefor
    • 取代的嘧啶-2-酮,其盐,其制备方法,含有它们的药物组合物及其方法
    • US4636509A
    • 1987-01-13
    • US498723
    • 1983-05-27
    • Gordon H. PhillippsChristopher Williamson
    • Gordon H. PhillippsChristopher Williamson
    • A61K31/505A61P35/00A61P35/02C07D239/36
    • C07D239/36
    • Compounds of the general formula: ##STR1## (wherein X represents a halogen atom or a trifluoromethyl group; R.sup.1 represents an optionally substituted C.sub.6-10 carbocyclic aromatic group; and R.sup.2 represents a hydrogen atom or a lower alkyl, C.sub.7-16 aralkyl or C.sub.6-10 aryl group or the group COR.sup.1a, in which R.sup.1a is as defined for R.sup.1, R.sup.1 and R.sup.1a being the same or different) and where an acidic or basic group is present, the salts thereof have been found to possess excellent metaphase arresting ability and are of use in combating abnormal cell proliferation. Thus a knowledge of the cell division cycles of the normal and abnormal cells enables a cytotoxic drug to be administered while the abnormal cells are in a phase susceptible to attack and while the normal cells are in a non-susceptible phase.The compounds of the invention are prepared by alkylation, deprotection of a protected keto group, oxidation or electrophilic halogenation.Pharmaceutical compositions containing the compounds of formula I, and where appropriate, the physiologically compatible salts thereof; and methods for the use of the compounds are described and claimed.
    • 通式为的化合物:其中X表示卤原子或三氟甲基; R 1表示任选取代的C 6-10碳环芳基; R 2表示氢原子或低级烷基,C 7-16芳烷基或 C6-10芳基或COR1a基团,其中R1a如R1所定义,R1和R1a相同或不同),并且其中存在酸性或碱性基团时,其盐被发现具有优异的中期阻滞能力 并且可用于对抗异常细胞增殖。 因此,正常和异常细胞的细胞分裂周期的知识使得能够施用细胞毒性药物,同时异常细胞处于易受攻击的阶段,而正常细胞处于非易感相。 本发明的化合物是通过烷基化,保护的酮基的脱保护,氧化或亲电卤化来制备的。 含有式I化合物和适当时其生理上相容的盐的药物组合物; 并描述和要求保护化合物的使用方法。